From USFDA
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg. The launch of this product is based on the settlement terms / litigation outcome with AstraZeneca.Powered by Capital Market - Live News
